Linda Jaber Pharm. D.
EACPHS, Room 2134
Professor, Department of Pharmacy Practice
Degrees and Certifications
PharmD, Wayne State University (Detroit, MI), 1986
B.S. in Pharmacy, Wayne State University (Detroit, MI), 1983
Medication Therapy Management, American Pharmacists Association, 2014
Positions and Employment
2009-present, Professor, Wayne State University (Detroit, MI)
1996-2008, Associate Professfor, Wayne State University (Detroit, MI)
1989-1996, Assistant Professor, Wayne State University (Detroit, MI)
1987-1989, Clinical Lecturer, Wayne State University (Detroit, MI)
Awards and Honors
Mortar and Pestle Award of Excellence, Arab American Pharmacist Association, 2009
Roche Preceptor Award, 2007-2008
Excellence in Research Award, Blue Cross Blue Shield of Michigan Foundation, 2006
Leadership Award for Community Research Collaboration, 2003
Excelennce in Teaching Award, Wayne State University, 2000-2001
Research Award, Michigan Society of Health-System Pharmacists, 1994-1995
Teacher of the Year, Wayne State University, 1993-1994
Instructor of the Year, Wayne State University, 1989-1990
Graduate/Professional Scholarship, Wayne State University, 1985-1986
American Diabetes Association
American Academy of Clinical Pharmacy
National Arab American Medical Association
Areas of Expertise
Diabetes management; clinical diabetes research; epidemiology and risk factors for diabetes in Arab Americans
McEwen LN, Ibrahim M, Ali NM, Assaad-Khalil SH, Tantawi HR, Nasr G, Mohammadmoradi S, Misha'l AA, Annabi FA, Ba-Essa EM, Bahijri SM, Tuomilehto J, Jaber LA, Herman WH. “Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan.” BMJ Open Diabetes Res Care. 2015; 16;3(1):e000111.
Jaber LA, Pinelli NR, Brown MB, Funnell M, Anderson R, Hammad A, Herman WH. “Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans.” Diabetes Res Clin Pract. 2011;91:307-315.
Pinelli NR, Brown MB, Herman WH, Jaber LA. “Family support is associated with success in achieving weight loss in a group lifestyle Intervention for diabetes prevention in Arab-Americans.” Ethn Dis 2011;21:480-484.
Pinelli NR, Brown MB, Herman WH, Jaber LA. “Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab Americans.” Diabetes Res Clin Pract. 2010;90:e27-29.
Kridli S, Brown MB, Herman WH, Jaber LA. “Prevalence of diabetes among Chaldean Americans." Ethn Dis 2006;16:351-6.
Hammad A, Herman WH, Jaber LA. "Cardiovascular risk factors in an Arab-American population in southeastern Michigan." Ethn Dis Winter 2005;15(1 Suppl 1):S1-29.
Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. “The prevalence of the metabolic syndrome among Arab Americans.” Diabetes Care 2004;27:234-238.
Jaber LA, Brown MB, Hammad A, Nowak SN, Zhu Q, Ghafoor A, Herman WH. “Epidemiology of diabetes among Arab Americans.” Diabetes Care 2003;26:308-313.
Jaber LA, Nowak SN, Slaughter RR. “Efficacy of insulin-metformin combination therapy in obese patients with type 2 diabetes.” J Clin Pharmacol 2002;42:89-94.
Jaber LA, Antal EJ, Welshman IR. "Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with NIDDM." Ann Pharmacother 1996;30:472-475.
Jaber LA, Antal EJ, Slaughter RL, Welshman IR. "Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM." Diabetes Care 1994;17:1300-1306.
Jaber LA, Antal EJ, Slaughter RL, Welshman IR. "The Pharmacokinetics and Pharmacodynamics of 12 week glyburide therapy in obese diabetics." Eur J Clin Pharmacol 1993;45:459-463.